Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00795639
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Single-Arm Study of Pralatrexate in Patients With Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00722553
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Placebo-Controlled, Double-Blind, Multi-Centre, 4-week, 3-way Crossover Pharmacodynamic Study to Assess the Equivalence of Budesonide, Glycopyrronium, and Formoterol Fumarate (BGF) Delivered by MDI HFO Compared With BGF Delivered by MDI HFA in Participants With Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 11 de ene de 2024
ID: NCT06075095
Terminado
Fase 4
ClinicalTrials.gov
Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT02342002
Completado
Fase 3
ClinicalTrials.gov
A Phase III Multicentre, Double Blind, Placebo-controlled, Parallel Group 52-week Study to Assess the Efficacy and Safety of 2 Dose Regimens of Lyophilised CDP870 as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms and Preventing Structural Damage in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de feb de 2005
ID: NCT00152386
Completado
Fase 2
ClinicalTrials.gov
A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Asses the Safety and Efficacy of Once-Daily KRP-104 in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Alone.
INTERVENTIONAL
Inicio: 1 de oct de 2009
ID: NCT00995345
Terminado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01110382
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue.
INTERVENTIONAL
Inicio: 1 de dic de 2004
ID: NCT00332488
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Study of Pembrolizumab in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Followed by Pembrolizumab and Maintenance Olaparib vs Maintenance Pemetrexed in the First-Line Treatment of Participants With Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 28 de jun de 2019
ID: NCT03976323
Completado
Fase 3
ClinicalTrials.gov
A Multi-center Trial Comparing the Efficacy and Safety of GSK573719/GW642444 With GSK573719 and With Tiotropium Over 24 Weeks in Subjects With COPD
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01316913
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes
INTERVENTIONAL
Inicio: 1 de sept de 2015
ID: NCT02531035
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Patients With Moderate to Severe Atopic Dermatitis
INTERVENTIONAL
Inicio: 27 de nov de 2017
ID: NCT03334422
Retirado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Adult Subjects Infected With Human Metapneumovirus
INTERVENTIONAL
Inicio: 5 de nov de 2018
ID: NCT03502694
Completado
Fase 1
ClinicalTrials.gov
A Phase Ib, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of RO7303509 in Participants With Systemic Sclerosis
INTERVENTIONAL
Inicio: 16 de ene de 2023
ID: NCT05462522
Completado
Fase 3
ClinicalTrials.gov
A Phase III Multicenter, Randomized Study of Oral LDK378 Versus Standard Chemotherapy in Previously Untreated Adult Patients With ALK Rearranged (ALK-positive), Stage IIIB or IV, Non-squamous Non-small Cell Lung Cancer
INTERVENTIONAL
Inicio: 9 de jul de 2013
ID: NCT01828099
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral Fasiglifam 25 mg and 50 mg Compared to Placebo When Used in Combination With Sitagliptin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2013
ID: NCT01829464
Completado
ClinicalTrials.gov
An Exploratory Study of the Effect of the Atazanavir (ATV) I50L Mutation on Subsequent Treatment Response
OBSERVATIONAL
Inicio: 1 de nov de 2004
ID: NCT00096746
Completado
ClinicalTrials.gov
Exploring the Effects of Non-ablative Er:YAG Laser on Patients Suffering From Recurrent Vulvovaginal Candidiasis
INTERVENTIONAL
Inicio: 3 de ene de 2019
ID: NCT06572488
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00679588
Completado
Fase 3
ClinicalTrials.gov
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
INTERVENTIONAL
Inicio: 31 de ago de 2013
ID: NCT01875003
Anterior
1
...
410
411
412
...
434
Siguiente
Filtros